Live from TTLC25: Targeted Therapy in SCLC Podcast

Podcast | English | 2025 | 29 Min

Create Account

Cost

$0.00

Credit

No Credit Offered

In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion on how small cell lung cancer continues to evolve with new treatment options and recent FDA approval. Listen to the episode to learn about the current standard of care and future therapies, with a brief discussion about small cell transformation.

Podcast Hosts:

Narjust Florez, MD, Associate Director of the Cancer Care Equity Program and Thoracic Medical Oncologist, Dana-Farber Cancer Institute; Assistant Professor of Medicine, Harvard Medical School, Boston, MA, USA

Podcast Guests:

Jacob Sands, MD, Assistant Professor of Medicine, Harvard Medical School, Lowe Cancer Center for Thoracic Oncology, Dana Farber Cancer Institute, Boston, MA, USA
Triparna Sen, MD, PhD, Associate Professor, Co-Director, Lung Cancer PDX Program, Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY, USA